Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

HHS, ONC finalize interoperability rules, mandating health record access

Patients will soon have free digital access to their health records thanks to the finalization of two new interoperability rules finalized by HHS and the National Coordinator for Health Information Technology (ONC). The rule also dictates how patient information is exchanged across the healthcare system.

Thumbnail

Aetna, Cigna waive costs of coronavirus testing for members

Health insurers are jumping on board to provide free diagnostic and telemedicine services to members at high risk of having the new coronavirus, COVID-19.

Thumbnail

Net prices of drugs have jumped 60% since 2007

The prices of prescription drugs have risen 60% over an 11-year period, as have discounts that widen medical gaps, according to a new study published in JAMA.

Thumbnail

$8.3B package for coronavirus approved

Congress approved an $8.3 billion package to fight the spread of coronavirus and respond to the growing crisis.

Thumbnail

FTC receives support––and pushback––for interfering in hospital merger

The healthcare industry has voiced its support and pushback after the FTC sued to block a merger between two hospital systems in Philadelphia.

Thumbnail

Supreme Court will take up ACA lawsuit

The Supreme Court will listen to the legal challenge to the Affordable Care Act that has been working its way through the lower courts. The court made its decision to hear the case Monday, March 2.

Thumbnail

FTC plans to kill a hospital merger

The FTC is moving to block a proposed merger between Jefferson Health and Einstein Healthcare Network, two Philadelphia-based health systems. The two entities have a combined annual revenue of $5.9 billion.

HHS mitigates coronavirus risks, asks for $2.5B in funding

The Trump administration recently asked Congress for $2.5 billion in funding to address the outbreak of the disease as the number of cases continues to grow worldwide.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.